Astrana Health, Inc.
ASTH
$29.19
-$0.64-2.15%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 40.81% | 196.27% | -143.19% | -16.05% | 29.23% |
| Total Depreciation and Amortization | 0.79% | -15.71% | 11.87% | -2.38% | 46.02% |
| Total Amortization of Deferred Charges | 51.81% | 52.20% | -0.66% | -0.44% | 0.22% |
| Total Other Non-Cash Items | 34.01% | -38.62% | 108.27% | -10.23% | 3.68% |
| Change in Net Operating Assets | 843.83% | 72.88% | -1,557.55% | 115.64% | 44.08% |
| Cash from Operations | 446.70% | 251.87% | -132.22% | 46.55% | 287.95% |
| Capital Expenditure | 53.75% | -21.30% | -10.28% | 19.08% | -668.56% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -3,284.60% | 98.58% | -26.23% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -49.26% | 2,603.70% | 99.45% | 62.72% | 34.30% |
| Cash from Investing | 55.01% | 92.82% | -311.05% | 89.86% | -12.51% |
| Total Debt Issued | -100.00% | -- | -100.00% | -97.42% | -45.16% |
| Total Debt Repaid | 99.30% | -3,346.89% | -216.88% | 46.43% | -98.99% |
| Issuance of Common Stock | -- | -42.45% | 3.98% | -- | -- |
| Repurchase of Common Stock | 67.87% | -346.75% | 18.14% | 69.08% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 85.74% | -- | -- | -- | -- |
| Other Financing Activities | 80.74% | -657.03% | -1,026.15% | 89.92% | -7,310.00% |
| Cash from Financing | 80.44% | -189.32% | -378.59% | -106.75% | -55.57% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 371.19% | 49.72% | -362.47% | 339.16% | -122.97% |